Premium
Glucose‐sensitive and blood‐compatible nanogels for insulin controlled release
Author(s) -
Zhou Xiaoyan,
Lin Anhua,
Yuan Xinxin,
Li Hui,
Ma Dong,
Xue Wei
Publication year - 2016
Publication title -
journal of applied polymer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.575
H-Index - 166
eISSN - 1097-4628
pISSN - 0021-8995
DOI - 10.1002/app.43504
Subject(s) - nanogel , insulin , in vivo , partial thromboplastin time , chemistry , hemolysis , methacrylic acid , polymerization , materials science , polymer chemistry , polymer , coagulation , medicine , drug delivery , biology , organic chemistry , microbiology and biotechnology
ABSTRACT For insulin delivery, many reported glucose‐sensitive materials are designed to response to the glucose in the blood. However, few particular studies on their blood compatibility have been reported. In this article, for controlled insulin release in diabetes therapy, a glucose‐sensitive nanogel was prepared through thermally initiated precipitation polymerization using the aminophenylboronic acid‐containing monomer to copolymerize with methacrylic acid. The obtained nanogels showed the uniform and spheroidal morphology as observed by SEM, and their sizes in aqueous solution are dependent on the concentration of glucose. Through in vitro and in vivo insulin release tests, it was found that nanogels showed the glucose‐dependent insulin release and prolonged effect of lowing blood glucose level. The blood compatibility of nanogels has also been explored through various assays including the hemolysis, activated partial thromboplastin time, prothrombin time as well as the thromboelastography. All results indicated that the obtained glucose‐sensitive nanogels showed good blood safety. Moreover, their low cytotoxicity suggested a potential application in diabetes therapy. © 2016 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2016 , 133 , 43504.